These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 23651359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6).
    Cingolani G, Panella A, Perrone MG, Vitale P, Di Mauro G, Fortuna CG, Armen RS, Ferorelli S, Smith WL, Scilimati A.
    Eur J Med Chem; 2017 Sep 29; 138():661-668. PubMed ID: 28710965
    [Abstract] [Full Text] [Related]

  • 4. Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles.
    Vitale P, Perrone MG, Malerba P, Lavecchia A, Scilimati A.
    Eur J Med Chem; 2014 Mar 03; 74():606-18. PubMed ID: 24531199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs).
    Perrone MG, Vitale P, Panella A, Ferorelli S, Contino M, Lavecchia A, Scilimati A.
    ChemMedChem; 2016 Jun 06; 11(11):1172-87. PubMed ID: 27136372
    [Abstract] [Full Text] [Related]

  • 8. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
    Di Nunno L, Vitale P, Scilimati A, Tacconelli S, Patrignani P.
    J Med Chem; 2004 Sep 23; 47(20):4881-90. PubMed ID: 15369392
    [Abstract] [Full Text] [Related]

  • 9. Nitrooxymethyl-substituted analogues of rofecoxib: synthesis and pharmacological characterization.
    Boschi D, Cena C, Di Stilo A, Rolando B, Manzini P, Fruttero R, Gasco A.
    Chem Biodivers; 2010 May 23; 7(5):1173-82. PubMed ID: 20491074
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
    Sakata C, Kawasaki T, Kato Y, Abe M, Suzuki K, Ohmiya M, Funatsu T, Morita Y, Okada M.
    Thromb Res; 2013 Jul 23; 132(1):56-62. PubMed ID: 23522855
    [Abstract] [Full Text] [Related]

  • 13. Design, Synthesis and Biological Evaluation of New 1,3-diphenyl-3- (phenylamino)propan-1-ones as Selective Cyclooxygenase (COX-2) Inhibitors.
    Farzaneh S, Shahhosseini S, Arefi H, Daraei B, Esfahanizadeh M, Zarghi A.
    Med Chem; 2018 Jul 23; 14(7):652-659. PubMed ID: 29804536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
    Zarghi A, Ghodsi R.
    Bioorg Med Chem; 2010 Aug 15; 18(16):5855-60. PubMed ID: 20650641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.